Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns

Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns

Introduction: Magnesium sulphate (MgSO4) therapy has shown to be useful as a neurological protector in the preterm newborn below 32 weeks of gestation. The most documented adverse effect is cardiorespiratory failure, whereas its relationship with meconium obstruction is controversial. The main objec...

Full description

Bibliographic Details
Main Authors: Ainhoa Gochi Valdovinos, María Arriaga-Redondo, Ester Dejuan Bitriá, Isabel Pérez Rodríguez, Elena Márquez Isidro, Dorotea Blanco Bravo
Format: Article
Language:Spanish
Published: Elsevier 2022-02-01
Series:Anales de Pediatría (English Edition)
Subjects:
Recién nacido prematuro
Sulfato de magnesio
Obstrucción meconial
Insuficiencia respiratoria
Insuficiencia cardíaca
Online Access:http://www.sciencedirect.com/science/article/pii/S2341287922000096

Internet

http://www.sciencedirect.com/science/article/pii/S2341287922000096

Similar Items